3-D Breast Tomosynthesis Market Forecast | 2023-28

Market Insights

The Global 3-D Breast Tomosynthesis Market is estimated to grow from USD 2.09 billion in 2022 to USD 3.84 billion by 2028 at a CAGR of 10.6% during the forecast period.

To know about the assumptions related to the report, Request for Free Sample here.

What is Breast tomosynthesis?

Breast tomosynthesis is an advanced form of mammography, a breast imaging technique that involves the usage of low-dose x-rays to treat cancer at a stage where it can be treated. It creates 3-D dimensional images of the breasts and thus, helps the physicians to diagnose and treat breast diseases. It is a non-invasive medical test. During this test, the X-ray tube moves in an arc over the compressed breast and captures images from different angles which are then reconstructed by the computer into 3-D images.

Key Players

Key players operating in the global 3-D Breast Tomosynthesis Market are-

• General Electric Company (The U.S),
• Hologic, Inc. (The U.S),
• Siemens AG (Germany),
• Dexela Limited (The U.S),
• FUJIFILM Holdings America Corporation (The U.S),
• Konica Minolta, Inc. (Japan), and
• Planmed Oy (Finland).

Market Dynamics

Growing emphasis on developing advanced solutions by the technology providers is likely to add to the market growth substantially.

• The growth of the global 3-D breast tomosynthesis market is primarily driven by increasing consumer breast cancer cases and the availability of advanced technologies to detect cancer early when it can be cured.
• It is being widely preferred to detect breast diseases as compared to 2D mammograms as the mammogram technique cannot detect all types of cancers. This is expected to propel the market growth at a significant rate during the review period.

Segment Analysis

End User Trends

The diagnostic centres segment is projected to register the fastest growth during the review period.

Based on end-users, the market has been segmented into hospitals, diagnostic centres, and others. The hospitals segment accounted for the largest market share in 2022. The segment growth can be attributed to the increasing prevalence of breast cancer across geographies.

Regional Trends

Geographically, the market in North America accounted for the largest market share in 2022.

• The regional market growth can be attributed to the rising number of breast cancer and the presence of advanced healthcare solutions.
• For instance, in the US, around 276,480 new cases of invasive breast cancer were diagnosed in women in 2022.
• The market in Asia-Pacific is expected to register the fastest growth during the review period on account of rising consumer awareness and increasing spending on healthcare.

COVID-19 Impact on the Global 3-D Breast Tomosynthesis Market

The COVID-19 outbreak did affect the growth of the 3-D breast tomosynthesis market for a short period as due to fear of coronavirus the number of women visiting the imaging centres for examination decreased and also some of the imaging centres were closed for a short period.

Critical Questions Answered in the Report

• What are the key trends in the global 3-D breast tomosynthesis market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the global 3-D breast tomosynthesis market?
• What are the key strategies adopted by the major vendors to lead in the global 3-D breast tomosynthesis market?
• What is the market share of the top vendors?

Target Audience

Here is the list of the group of customers that the Global 3D breast tomosynthesis market hopes to have the greatest opportunity to convert-

• 3-D breast tomosynthesis manufacturers
• 3-D breast tomosynthesis suppliers
• 3-D breast tomosynthesis distributors
• Organizations
• Government bodies

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market. 

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.